Stay updated with breaking news from Managed Access Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A staggering Rs 17 crore for a single jab! That’s the cost of one Zolgensma injection used for children under two suffering from spinal muscular atrophy (SMA), the...
(This story has not been edited by THE WEEK and is auto-generated from a PTI
The gene therapy, one of the world’s most expensive drugs, offers promising results but experts caution that it is not a definitive solution for the rare nerve condition that leads to muscle wasting and weakness
New Delhi: A staggering Rs 17 crore for a single jab! That’s the cost of one Zolgensma injection used for children under two suffering from spinal muscular atrophy...
Althea Group Holdings Limited (ASX: AGH), an Australian manufacturer of cannabis-based medicines and recreational cannabis products confirmed that Ireland’s Primary Care Reimbursement Service (‘PCRS’) has approved Althea THC20:CBD1 cannabis oil for reimbursement in Ireland. The company’s sub